704 related articles for article (PubMed ID: 1318558)
21. [MRI imaging of liver neoplasma].
Mio A; Suzuki T; Suzaki K
Rinsho Hoshasen; 1989 Dec; 34(13):1579-84. PubMed ID: 2560082
[TBL] [Abstract][Full Text] [Related]
22. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
23. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of breath-hold multislice dynamic MRI of hepatocellular carcinomas].
Itoh K; Honjo K; Honma Y; Hatanaka M; Choji T; Uchisako H; Kuramitsu T; Tanaka N; Nakaki H; Matsumoto T
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Mar; 52(3):399-401. PubMed ID: 1315953
[TBL] [Abstract][Full Text] [Related]
25. Cardiac tumors: assessment with Gd-DTPA enhanced MR imaging.
Funari M; Fujita N; Peck WW; Higgins CB
J Comput Assist Tomogr; 1991; 15(6):953-8. PubMed ID: 1939774
[TBL] [Abstract][Full Text] [Related]
26. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
27. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
[TBL] [Abstract][Full Text] [Related]
28. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.
Reimer P; Rummeny EJ; Daldrup HE; Hesse T; Balzer T; Tombach B; Peters PE
Eur Radiol; 1997; 7(2):275-80. PubMed ID: 9038130
[TBL] [Abstract][Full Text] [Related]
29. Hepatic tumors: dynamic MR imaging.
Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Yashiro N; Iio M; Furukawa K
Radiology; 1987 Apr; 163(1):27-31. PubMed ID: 3029804
[TBL] [Abstract][Full Text] [Related]
30. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
[TBL] [Abstract][Full Text] [Related]
32. [Gd-DTPA in the MR diagnosis of pituitary adenomas].
Steiner E; Wimberger D; Imhof H; Knosp E; Hajek P
Rofo; 1989 Mar; 150(3):323-7. PubMed ID: 2538883
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
34. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
36. [The tissue characterization of focal liver lesions with magnetic resonance imaging].
Manfredi R; Maresca G; De Gaetano AM; De Franco A; Marano P
Radiol Med; 1995 Sep; 90(3):250-61. PubMed ID: 7501830
[TBL] [Abstract][Full Text] [Related]
37. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T.
Schmiedl U; Kölbel G; Hess CF; Klose U; Kurtz B
J Comput Assist Tomogr; 1990; 14(4):600-7. PubMed ID: 2164538
[TBL] [Abstract][Full Text] [Related]
38. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging.
Hamm B; Fischer E; Taupitz M
J Comput Assist Tomogr; 1990; 14(2):205-16. PubMed ID: 2312848
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]